Dorchester Wealth Management CO Gilead Sciences, Inc. Transaction History

Dorchester Wealth Management CO

$560 Million
Q3 2024

A detailed history of Dorchester Wealth Management CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Dorchester Wealth Management CO holds 14,358 shares of GILD stock, worth $1.29 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

14,358

Previous 14,558 1.37%

Holding current value

$1.29 Million

Previous $998,000 20.54%

% of portfolio

0.21%

Previous 0.19%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$66.59 - $83.99 $13,318 - $16,798	-200 Reduced 1.37%	14,358 $1.2 Million
Q2 2024 Jul 23, 2024	SELL	$63.15 - $72.88 $78,306 - $90,371	-1,240 Reduced 7.85%	14,558 $998,000
Q1 2024 Apr 30, 2024	SELL	$71.58 - $87.29 $12,168 - $14,839	-170 Reduced 1.06%	15,798 $1.16 Million
Q4 2023 Jan 23, 2024	SELL	$73.27 - $83.09 $27,696 - $31,408	-378 Reduced 2.31%	15,968 $1.29 Million
Q3 2023 Oct 24, 2023	BUY	$73.94 - $80.67 $991,239 - $1.08 Million	13,406 Added 455.99%	16,346 $1.22 Million
Q2 2023 Jul 13, 2023	SELL	$76.01 - $86.7 $2,280 - $2,601	-30 Reduced 1.01%	2,940 $226,000
Q1 2023 Apr 26, 2023	SELL	$77.31 - $88.08 $76,536 - $87,199	-990 Reduced 25.0%	2,970 $246,000
Q4 2022 Jan 31, 2023	SELL	$62.32 - $89.47 $46,116 - $66,207	-740 Reduced 15.74%	3,960 $339,000
Q3 2022 Oct 24, 2022	SELL	$59.54 - $68.01 $17,862 - $20,403	-300 Reduced 6.0%	4,700 $290,000
Q2 2022 Aug 04, 2022	BUY	$57.72 - $65.01 $98,701 - $111,167	1,710 Added 51.98%	5,000 $309,000
Q1 2022 May 10, 2022	BUY	$57.92 - $72.58 $5,792 - $7,258	100 Added 3.13%	3,290 $244,000
Q4 2021 Feb 08, 2022	BUY	$64.88 - $73.64 $3,244 - $3,682	50 Added 1.59%	3,190 $232,000
Q2 2021 Jul 22, 2021	BUY	$63.47 - $69.35 $199,295 - $217,758	3,140 New	3,140 $216,000
Q1 2020 Apr 16, 2020	SELL	$62.63 - $80.22 $5.08 Million - $6.5 Million	-81,078 Closed	0 $0
Q4 2019 Jan 21, 2020	BUY	$61.62 - $67.78 $37,588 - $41,345	610 Added 0.76%	81,078 $5.27 Million
Q3 2019 Oct 18, 2019	BUY	$62.51 - $69.0 $625 - $690	10 Added 0.01%	80,468 $5.1 Million
Q2 2019 Jul 19, 2019	BUY	$61.87 - $69.38 $5,568 - $6,244	90 Added 0.11%	80,458 $5.44 Million
Q1 2019 Apr 17, 2019	BUY	$62.53 - $70.05 $108,739 - $121,816	1,739 Added 2.21%	80,368 $5.23 Million
Q4 2018 Jan 17, 2019	SELL	$60.54 - $79.0 $544 - $711	-9 Reduced 0.01%	78,629 $4.92 Million
Q3 2018 Oct 16, 2018	BUY	$71.28 - $78.92 $986,158 - $1.09 Million	13,835 Added 21.35%	78,638 $6.07 Million
Q2 2018 Jul 17, 2018	SELL	$64.88 - $75.68 $133,004 - $155,144	-2,050 Reduced 3.07%	64,803 $4.59 Million
Q1 2018 Apr 20, 2018	SELL	$72.84 - $88.8 $40,790 - $49,728	-560 Reduced 0.83%	66,853 $5.04 Million
Q4 2017 Jan 18, 2018	SELL	$71.15 - $83.52 $159,731 - $187,502	-2,245 Reduced 3.22%	67,413 $4.83 Million
Q3 2017 Oct 19, 2017	BUY	$72.11 - $85.47 $5.02 Million - $5.95 Million	69,658	69,658 $5.64 Million

Others Institutions Holding GILD

# of Institutions

1,924

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dorchester Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Dorchester Wealth Management CO with notifications on news.

Account

Dorchester Wealth Management CO Gilead Sciences, Inc. Transaction History